A DTAP–IPV//PRP~T VACCINE: A REVIEW OF 16 YEARS’ CLINICAL EXPERIENCE
Owing to their low reactogenicity, confirmed efficacy and availability in combination vaccines, acellular pertussis (aP)-inactivated poliovirus (IPV) combined vaccines are now included in various national immunization programs worldwide. We provide an overview of 16 years of clinical experience with...
Saved in:
Main Authors: | Stanley A. Plotkin, Johannes Liese, Shabir A. Madhi, Esteban Ortiz |
---|---|
Format: | Article |
Language: | English |
Published: |
"Paediatrician" Publishers LLC
2012-01-01
|
Series: | Вопросы современной педиатрии |
Subjects: | |
Online Access: | https://vsp.spr-journal.ru/jour/article/view/507 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Implementation of Pentavalent Vaccine DTaP/IPV/Hib within National Immunization Schedule
by: Irina V. Mikheeva, et al.
Published: (2019-09-01) -
Safety and Immunogenicity of Fully Liquid Hexavalent DTaP-IPV-HepB-Hib Vaccine in Healthy Infants in Russian Federation
by: L. S. Namazova-Baranova, et al.
Published: (2019-06-01) -
RESULTS OF ADMINISTRATION OF COMBINED VACCINE AGAINST DIPHTHERIA, PERTUSSIS, TETANUS, POLIOMYELITIS AND HAEMOPHILIC INFECTION TYPE B IN CHILDREN WITH CONCOMITANT DISEASES
by: N. F. Snegova, et al.
Published: (2011-01-01) -
The estimation of safety booster vaccination children is more senior than 1,5 years against diphtheria, perussis, tetanus, poliomyelitis and Haemophilus influenzae type B with Pentaxim
by: S. M. Harit, et al.
Published: (2014-09-01) -
Vaccine interchangeability: problems and prospects
by: N. A. Gavrilova, et al.
Published: (2021-10-01)